Uber Rolls Out 'Autonomous Solutions' Platform For Robotaxi Makers As AV Competition Heats Up Uber stock was slightly lower as the company announced plans for "Uber Autonomous Solutions" designed to boost robotaxi partners.
Getty Images Stock Surges After DOJ Clears Shutterstock Merger Getty Images Holdings shares are trading higher Monday after the DOJ cleared its proposed merger with Shutterstock, Inc. (
NYSE:SSTK ).
AI Disruption Is Reshaping Software — And Credit Markets May Be Next AI may trigger deflation, compress software valuations and widen dispersion, reshaping winners across various markets, Jordi Visser says.
Dog And Cat Food Maker Freshpet Issues Cautious Outlook Freshpet Inc. (FRPT) stock slips despite Q4 earnings beat and 8.6% sales growth. CEO highlights lessons learned and plans for future growth.
SPAI Stock Jumps 8% Pre-Market – What’s The Update On The US Government Subcontract? The company said it expects first-quarter revenue to surge more than 500% due to the initial deliveries under a recently awarded U.S. government subcontract.
Tom Lee: Bitcoin's 50% Drop Is A 'Crypto Squall,' Not A Winter Fundstrat’s Tom Lee called Bitcoin’s (CRYPTO: BTC) 50% drawdown a “crypto squall” rather than a structural collapse, arguing t
Merck's Strategic Shift Signals New Growth Horizons Merck restructures its Human Health business as Keytruda faces a 2028 patent loss.
Eli Lilly Announces New Version Of Zepbound With A Month’s Worth Of Doses In KwikPen — How Much Will It Cost? The new Zepbound KwikPen can be purchased by cash-paying customers through LillyDirect, Eli Lilly’s direct-to-customer website.
This Basing Israeli Solar Stock Is Set to Go On The AI Offensive In 2026 SolarEdge stock is up more than 30% in the 2026 stock market and analysts see data center opportunities for the solar company.
This AI Stock Soared 92% Last Year. Is It Still a Buy for 2026? This new company is riding the AI data center spending spree better than anyone.
MoonLake Immunotherapeutics Data Shows Phase 2 Success For Chronic Back Pain MoonLake stock rises after Phase 2 trial shows 81% response in chronic back pain study, boosting investor confidence Monday.
Hims & Hers In Focus Before Q4 Earnings Release Hims & Hers Health is in the spotlight Monday as the company prepares to report fourth-quarter earnings after the market closes.
DJT Stock Draws Bearish Retail Buzz On Tariff Turmoil And Supreme Court Ruling On Friday, the U.S. Supreme Court struck down President Donald Trump’s tariffs, citing that he exceeded his authority by invoking an emergency-powers law.
4 Things You Need to Know Before Allergy Season (BPT) - As spring draws near, allergy season follows close behind. While blooming flowers and budding trees may be welcome, they can also bring allergens that trigger sneezing, congestion and itchy, watery eyes for millions. Allergies are nothing to sneeze at: they currently affect approximately 30% of adults and 40% of children in the U.S., making them an ongoing struggle for many.
Vanda Pharmaceuticals FDA Approval Dawns A New Era For Bipolar And Schizophrenia Treatment Vanda shares rise after FDA approves Bysanti for bipolar I and schizophrenia, with launch planned for 2026.
Gold vs. Silver Showdown: Should You Buy SGDM or SIL ETF? Explore how these miner ETFs differ in risk, cost, and portfolio makeup -- key factors for refining a precious metals strategy.
Nvidia May Have Dumped Arm Stock in Q4, But Should You Buy Shares Now? With Nvidia dumping its entire stake in Arm Holdings, is this a red flag or a timely buying opportunity for investors?
